0001209191-23-016778.txt : 20230307 0001209191-23-016778.hdr.sgml : 20230307 20230307163835 ACCESSION NUMBER: 0001209191-23-016778 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160803 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abdun-Nabi Daniel CENTRAL INDEX KEY: 0001380187 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 23713144 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DRIVE STREET 2: SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2016-08-03 2016-08-05 0 0001671584 Aptevo Therapeutics Inc. APVO 0001380187 Abdun-Nabi Daniel C/O APTEVO THERAPEUTICS INC. 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 1 0 0 0 Common Stock 41762 D The number of shares has been adjusted to reflect the correct number of shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective August 1, 2016. On March 26, 2020, the Issuer effected a reverse stock split at a ratio of 1-for-14, resulting in every 14 shares owned by the reporting person to be combined into one share of common stock, thus reducing the number of shares owned by the reporting person to 4,173 as of March 26, 2020. /s/ SoYoung Kwon, Attorney-in-Fact 2023-03-07